Skip to content
Telehealth Graded
State guide

Alabama Medicaid and GLP-1s

Alabama's drug list carries both weight-management GLP-1s and a footnote under each that takes the weight indication back. Zepbound is preferred for obstructive sleep apnea with obesity and non-covered for weight reduction without it. Wegovy is available by authorization for cardiovascular risk and liver disease, and non-covered for weight reduction. The criteria document behind the footnotes requires no diagnosis of diabetes on any of these routes.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
6
sourced facts
2
primary sources

What changed, and what the document says

  1. Zepbound is preferred, for one diagnosis

    Conditions apply

    The footnote scopes the preferred status to a single indication rather than to the drug.

    Zepbound is preferred with clinical criteria for

    Alabama Medicaid AgencyEffective 07/01/2026

  2. And non-covered without it

    Not covered

    The second half of the same footnote is the refusal, in the list's own words.

    Zepbound is non-covered for weight

    Alabama Medicaid AgencyEffective 07/01/2026

  3. Wegovy carries the same sentence

    Not covered

    Alabama added Wegovy to the list effective July 2026 and excluded the weight indication in the same act.

    Wegovy is non-covered for weight reduction.

    Alabama Medicaid AgencyEffective 07/01/2026

  4. No diabetes diagnosis on these routes

    Conditions apply

    The criteria put the sleep-apnea threshold and the age floor in one sentence, and close it by excluding diabetes.

    moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] ≥15)

    Alabama Medicaid Agency, Division of Pharmacy ServicesEffective 07/01/2026

  5. Counseling, and no stacking

    Conditions apply

    Both conditions are in one attestation, so a prescriber confirms them together.

    The patient has been counseled to continue a reduced-calorie diet and increased physical activity

    Alabama Medicaid Agency, Division of Pharmacy ServicesEffective 07/01/2026

  6. The liver route needs documentation of the indication

    Conditions apply

    Alabama's MASH pathway is conditioned on evidence for the labeled indication and, again, on not having diabetes.

    with no diagnosis of diabetes.

    Alabama Medicaid Agency, Division of Pharmacy ServicesEffective 07/01/2026

Which of these companies serve Alabama?

Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.

10 of those lists name Alabama: Gala Health, Care Bare Rx, TelePeptide, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.